Immunogenicity of BNT162b2 and CoronaVac boosters in fully vaccinated individuals with CoronaVac against SARS-CoV-2: A Longitudinal Study
Zeynep Ece Kuloğlu1,2,*, Rojbin El1,2,*, Gülen Guney-Esken2, Yeşim Tok3, Zeynep Gülçe Talay1,2, Tayfun Barlas2, Mert Ahmet Kuskucu2,3, Özgür Albayrak4, Özlem Doğan2,5, Serap Şimşek Yavuz6, Kenan Midilli3, Önder Ergönül2,7, Füsun Can2,6,**
1Koc University School of Medicine, Graduate School of Health Sciences
2Koc University IsBank Research Center for Infectious Diseases (KUISCID), Istanbul, Turkey
3Cerrahpasa School of Medicine, Department of Medical Microbiology, Istanbul, Turkey
4Koc University Hospital Research Center for Translational Medicine
5Koc University School of Medicine, Department of Medical Microbiology, Istanbul, Turkey
6Istanbul University Capa School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
7Koc University School of Medicine, Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey
*First authors performed equal work in the study.
**Corresponding author, email: fucan@ku.edu.tr